nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A8—Mercaptopurine—hematologic cancer	0.0816	0.643	CbGbCtD
Cefadroxil—SLC22A8—Methotrexate—hematologic cancer	0.0267	0.21	CbGbCtD
Cefadroxil—SLC22A6—Methotrexate—hematologic cancer	0.0186	0.146	CbGbCtD
Cefadroxil—Cefazolin—PON1—hematologic cancer	0.00317	0.351	CrCbGaD
Cefadroxil—Cefdinir—MPO—hematologic cancer	0.0013	0.144	CrCbGaD
Cefadroxil—Cefaclor—MPO—hematologic cancer	0.00128	0.142	CrCbGaD
Cefadroxil—Cefpiramide—ALB—hematologic cancer	0.000835	0.0927	CrCbGaD
Cefadroxil—Cefonicid—ALB—hematologic cancer	0.000728	0.0807	CrCbGaD
Cefadroxil—Cefoperazone—ALB—hematologic cancer	0.000429	0.0476	CrCbGaD
Cefadroxil—Ampicillin—ALB—hematologic cancer	0.000365	0.0405	CrCbGaD
Cefadroxil—Cefazolin—ALB—hematologic cancer	0.000352	0.0391	CrCbGaD
Cefadroxil—Cefalotin—ALB—hematologic cancer	0.000293	0.0325	CrCbGaD
Cefadroxil—Agranulocytosis—Methotrexate—hematologic cancer	0.000268	0.00031	CcSEcCtD
Cefadroxil—Convulsion—Dexamethasone—hematologic cancer	0.000267	0.000309	CcSEcCtD
Cefadroxil—Convulsion—Betamethasone—hematologic cancer	0.000267	0.000309	CcSEcCtD
Cefadroxil—Headache—Thiotepa—hematologic cancer	0.000266	0.000308	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	0.000266	0.000308	CcSEcCtD
Cefadroxil—Cephalexin—ALB—hematologic cancer	0.000266	0.0295	CrCbGaD
Cefadroxil—Diarrhoea—Ifosfamide—hematologic cancer	0.000265	0.000306	CcSEcCtD
Cefadroxil—Pancytopenia—Doxorubicin—hematologic cancer	0.000265	0.000306	CcSEcCtD
Cefadroxil—Nausea—Vinorelbine—hematologic cancer	0.000264	0.000306	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000264	0.000305	CcSEcCtD
Cefadroxil—Body temperature increased—Cisplatin—hematologic cancer	0.000264	0.000305	CcSEcCtD
Cefadroxil—Asthenia—Mitoxantrone—hematologic cancer	0.000263	0.000305	CcSEcCtD
Cefadroxil—Asthenia—Irinotecan—hematologic cancer	0.000263	0.000305	CcSEcCtD
Cefadroxil—Vomiting—Thalidomide—hematologic cancer	0.000261	0.000303	CcSEcCtD
Cefadroxil—Dizziness—Carmustine—hematologic cancer	0.000261	0.000302	CcSEcCtD
Cefadroxil—Neutropenia—Doxorubicin—hematologic cancer	0.00026	0.000301	CcSEcCtD
Cefadroxil—Rash—Thalidomide—hematologic cancer	0.000259	0.0003	CcSEcCtD
Cefadroxil—Dermatitis—Thalidomide—hematologic cancer	0.000259	0.0003	CcSEcCtD
Cefadroxil—Haemoglobin—Methotrexate—hematologic cancer	0.000259	0.000299	CcSEcCtD
Cefadroxil—Dizziness—Alitretinoin—hematologic cancer	0.000259	0.000299	CcSEcCtD
Cefadroxil—Diarrhoea—Vincristine—hematologic cancer	0.000258	0.000298	CcSEcCtD
Cefadroxil—Headache—Thalidomide—hematologic cancer	0.000258	0.000298	CcSEcCtD
Cefadroxil—Haemorrhage—Methotrexate—hematologic cancer	0.000257	0.000298	CcSEcCtD
Cefadroxil—Asthenia—Gemcitabine—hematologic cancer	0.000257	0.000297	CcSEcCtD
Cefadroxil—Dizziness—Ifosfamide—hematologic cancer	0.000256	0.000296	CcSEcCtD
Cefadroxil—Pruritus—Gemcitabine—hematologic cancer	0.000253	0.000293	CcSEcCtD
Cefadroxil—Nausea—Thiotepa—hematologic cancer	0.000253	0.000292	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000252	0.000292	CcSEcCtD
Cefadroxil—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000251	0.000291	CcSEcCtD
Cefadroxil—Anaphylactic shock—Betamethasone—hematologic cancer	0.000251	0.000291	CcSEcCtD
Cefadroxil—Diarrhoea—Irinotecan—hematologic cancer	0.000251	0.000291	CcSEcCtD
Cefadroxil—Diarrhoea—Mitoxantrone—hematologic cancer	0.000251	0.000291	CcSEcCtD
Cefadroxil—Vomiting—Carmustine—hematologic cancer	0.000251	0.000291	CcSEcCtD
Cefadroxil—Agranulocytosis—Epirubicin—hematologic cancer	0.00025	0.00029	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Etoposide—hematologic cancer	0.00025	0.000289	CcSEcCtD
Cefadroxil—Dizziness—Vincristine—hematologic cancer	0.000249	0.000288	CcSEcCtD
Cefadroxil—Rash—Carmustine—hematologic cancer	0.000249	0.000288	CcSEcCtD
Cefadroxil—Dermatitis—Carmustine—hematologic cancer	0.000249	0.000288	CcSEcCtD
Cefadroxil—Vomiting—Alitretinoin—hematologic cancer	0.000249	0.000288	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—hematologic cancer	0.000248	0.000287	CcSEcCtD
Cefadroxil—Headache—Carmustine—hematologic cancer	0.000247	0.000286	CcSEcCtD
Cefadroxil—Rash—Alitretinoin—hematologic cancer	0.000247	0.000285	CcSEcCtD
Cefadroxil—Dermatitis—Alitretinoin—hematologic cancer	0.000246	0.000285	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000246	0.000285	CcSEcCtD
Cefadroxil—Thrombocytopenia—Betamethasone—hematologic cancer	0.000246	0.000285	CcSEcCtD
Cefadroxil—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000246	0.000285	CcSEcCtD
Cefadroxil—Vomiting—Ifosfamide—hematologic cancer	0.000246	0.000284	CcSEcCtD
Cefadroxil—Hypersensitivity—Cisplatin—hematologic cancer	0.000246	0.000284	CcSEcCtD
Cefadroxil—Headache—Alitretinoin—hematologic cancer	0.000245	0.000284	CcSEcCtD
Cefadroxil—Angioedema—Prednisone—hematologic cancer	0.000245	0.000284	CcSEcCtD
Cefadroxil—Diarrhoea—Gemcitabine—hematologic cancer	0.000245	0.000283	CcSEcCtD
Cefadroxil—Nausea—Thalidomide—hematologic cancer	0.000244	0.000283	CcSEcCtD
Cefadroxil—Dyspepsia—Triamcinolone—hematologic cancer	0.000244	0.000282	CcSEcCtD
Cefadroxil—Rash—Ifosfamide—hematologic cancer	0.000244	0.000282	CcSEcCtD
Cefadroxil—Dermatitis—Ifosfamide—hematologic cancer	0.000244	0.000282	CcSEcCtD
Cefadroxil—Erythema multiforme—Methotrexate—hematologic cancer	0.000243	0.000282	CcSEcCtD
Cefadroxil—Dizziness—Irinotecan—hematologic cancer	0.000243	0.000281	CcSEcCtD
Cefadroxil—Urticaria—Etoposide—hematologic cancer	0.000243	0.000281	CcSEcCtD
Cefadroxil—Haemoglobin—Epirubicin—hematologic cancer	0.000242	0.00028	CcSEcCtD
Cefadroxil—Body temperature increased—Etoposide—hematologic cancer	0.000241	0.000279	CcSEcCtD
Cefadroxil—Abdominal pain—Etoposide—hematologic cancer	0.000241	0.000279	CcSEcCtD
Cefadroxil—Vertigo—Prednisone—hematologic cancer	0.000241	0.000279	CcSEcCtD
Cefadroxil—Haemorrhage—Epirubicin—hematologic cancer	0.000241	0.000279	CcSEcCtD
Cefadroxil—Vomiting—Vincristine—hematologic cancer	0.00024	0.000277	CcSEcCtD
Cefadroxil—Urticaria—Prednisolone—hematologic cancer	0.000239	0.000277	CcSEcCtD
Cefadroxil—Asthenia—Cisplatin—hematologic cancer	0.000239	0.000277	CcSEcCtD
Cefadroxil—Rash—Vincristine—hematologic cancer	0.000238	0.000275	CcSEcCtD
Cefadroxil—Dermatitis—Vincristine—hematologic cancer	0.000237	0.000275	CcSEcCtD
Cefadroxil—Headache—Vincristine—hematologic cancer	0.000236	0.000273	CcSEcCtD
Cefadroxil—Nausea—Carmustine—hematologic cancer	0.000235	0.000271	CcSEcCtD
Cefadroxil—Vomiting—Irinotecan—hematologic cancer	0.000233	0.00027	CcSEcCtD
Cefadroxil—Vomiting—Mitoxantrone—hematologic cancer	0.000233	0.00027	CcSEcCtD
Cefadroxil—Nausea—Alitretinoin—hematologic cancer	0.000232	0.000269	CcSEcCtD
Cefadroxil—Convulsion—Prednisone—hematologic cancer	0.000232	0.000269	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—hematologic cancer	0.000232	0.000268	CcSEcCtD
Cefadroxil—Rash—Irinotecan—hematologic cancer	0.000231	0.000268	CcSEcCtD
Cefadroxil—Rash—Mitoxantrone—hematologic cancer	0.000231	0.000268	CcSEcCtD
Cefadroxil—Dermatitis—Mitoxantrone—hematologic cancer	0.000231	0.000268	CcSEcCtD
Cefadroxil—Dermatitis—Irinotecan—hematologic cancer	0.000231	0.000268	CcSEcCtD
Cefadroxil—Headache—Mitoxantrone—hematologic cancer	0.00023	0.000266	CcSEcCtD
Cefadroxil—Headache—Irinotecan—hematologic cancer	0.00023	0.000266	CcSEcCtD
Cefadroxil—Nausea—Ifosfamide—hematologic cancer	0.00023	0.000266	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000229	0.000265	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000229	0.000265	CcSEcCtD
Cefadroxil—Arthralgia—Prednisone—hematologic cancer	0.000228	0.000264	CcSEcCtD
Cefadroxil—Diarrhoea—Cisplatin—hematologic cancer	0.000228	0.000264	CcSEcCtD
Cefadroxil—Erythema multiforme—Epirubicin—hematologic cancer	0.000228	0.000264	CcSEcCtD
Cefadroxil—Vomiting—Gemcitabine—hematologic cancer	0.000227	0.000263	CcSEcCtD
Cefadroxil—Rash—Gemcitabine—hematologic cancer	0.000226	0.000261	CcSEcCtD
Cefadroxil—Dermatitis—Gemcitabine—hematologic cancer	0.000225	0.000261	CcSEcCtD
Cefadroxil—Hypersensitivity—Etoposide—hematologic cancer	0.000225	0.00026	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—hematologic cancer	0.000224	0.000259	CcSEcCtD
Cefadroxil—Headache—Gemcitabine—hematologic cancer	0.000224	0.000259	CcSEcCtD
Cefadroxil—Nausea—Vincristine—hematologic cancer	0.000224	0.000259	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—hematologic cancer	0.000223	0.000258	CcSEcCtD
Cefadroxil—Hypersensitivity—Prednisolone—hematologic cancer	0.000222	0.000257	CcSEcCtD
Cefadroxil—Dyspepsia—Dexamethasone—hematologic cancer	0.000221	0.000256	CcSEcCtD
Cefadroxil—Dyspepsia—Betamethasone—hematologic cancer	0.000221	0.000256	CcSEcCtD
Cefadroxil—Urticaria—Triamcinolone—hematologic cancer	0.00022	0.000255	CcSEcCtD
Cefadroxil—Asthenia—Etoposide—hematologic cancer	0.000219	0.000254	CcSEcCtD
Cefadroxil—Body temperature increased—Triamcinolone—hematologic cancer	0.000219	0.000253	CcSEcCtD
Cefadroxil—Anaphylactic shock—Prednisone—hematologic cancer	0.000219	0.000253	CcSEcCtD
Cefadroxil—Nausea—Irinotecan—hematologic cancer	0.000218	0.000252	CcSEcCtD
Cefadroxil—Nausea—Mitoxantrone—hematologic cancer	0.000218	0.000252	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000217	0.000251	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000217	0.000251	CcSEcCtD
Cefadroxil—Pruritus—Etoposide—hematologic cancer	0.000216	0.00025	CcSEcCtD
Cefadroxil—Nausea—Gemcitabine—hematologic cancer	0.000212	0.000246	CcSEcCtD
Cefadroxil—Vomiting—Cisplatin—hematologic cancer	0.000212	0.000245	CcSEcCtD
Cefadroxil—Erythema multiforme—Doxorubicin—hematologic cancer	0.000211	0.000244	CcSEcCtD
Cefadroxil—Rash—Cisplatin—hematologic cancer	0.00021	0.000243	CcSEcCtD
Cefadroxil—Dermatitis—Cisplatin—hematologic cancer	0.00021	0.000243	CcSEcCtD
Cefadroxil—Diarrhoea—Etoposide—hematologic cancer	0.000209	0.000242	CcSEcCtD
Cefadroxil—Tension—Epirubicin—hematologic cancer	0.000206	0.000238	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000206	0.000238	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000206	0.000238	CcSEcCtD
Cefadroxil—Hypersensitivity—Triamcinolone—hematologic cancer	0.000204	0.000236	CcSEcCtD
Cefadroxil—Nervousness—Epirubicin—hematologic cancer	0.000204	0.000236	CcSEcCtD
Cefadroxil—Dizziness—Etoposide—hematologic cancer	0.000202	0.000234	CcSEcCtD
Cefadroxil—Muscle spasms—Epirubicin—hematologic cancer	0.000202	0.000233	CcSEcCtD
Cefadroxil—Vertigo—Methotrexate—hematologic cancer	0.000201	0.000233	CcSEcCtD
Cefadroxil—Urticaria—Dexamethasone—hematologic cancer	0.0002	0.000231	CcSEcCtD
Cefadroxil—Urticaria—Betamethasone—hematologic cancer	0.0002	0.000231	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000199	0.000231	CcSEcCtD
Cefadroxil—Dizziness—Prednisolone—hematologic cancer	0.000199	0.00023	CcSEcCtD
Cefadroxil—Asthenia—Triamcinolone—hematologic cancer	0.000199	0.00023	CcSEcCtD
Cefadroxil—Abdominal pain—Dexamethasone—hematologic cancer	0.000199	0.00023	CcSEcCtD
Cefadroxil—Body temperature increased—Betamethasone—hematologic cancer	0.000199	0.00023	CcSEcCtD
Cefadroxil—Abdominal pain—Betamethasone—hematologic cancer	0.000199	0.00023	CcSEcCtD
Cefadroxil—Body temperature increased—Dexamethasone—hematologic cancer	0.000199	0.00023	CcSEcCtD
Cefadroxil—Nausea—Cisplatin—hematologic cancer	0.000198	0.000229	CcSEcCtD
Cefadroxil—Pruritus—Triamcinolone—hematologic cancer	0.000196	0.000227	CcSEcCtD
Cefadroxil—Convulsion—Methotrexate—hematologic cancer	0.000194	0.000225	CcSEcCtD
Cefadroxil—Vomiting—Etoposide—hematologic cancer	0.000194	0.000225	CcSEcCtD
Cefadroxil—Dyspepsia—Prednisone—hematologic cancer	0.000193	0.000223	CcSEcCtD
Cefadroxil—Rash—Etoposide—hematologic cancer	0.000193	0.000223	CcSEcCtD
Cefadroxil—Dermatitis—Etoposide—hematologic cancer	0.000192	0.000223	CcSEcCtD
Cefadroxil—Headache—Etoposide—hematologic cancer	0.000191	0.000221	CcSEcCtD
Cefadroxil—Arthralgia—Methotrexate—hematologic cancer	0.000191	0.000221	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—hematologic cancer	0.00019	0.00022	CcSEcCtD
Cefadroxil—Rash—Prednisolone—hematologic cancer	0.00019	0.00022	CcSEcCtD
Cefadroxil—Dermatitis—Prednisolone—hematologic cancer	0.00019	0.00022	CcSEcCtD
Cefadroxil—Headache—Prednisolone—hematologic cancer	0.000189	0.000218	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—hematologic cancer	0.000189	0.000218	CcSEcCtD
Cefadroxil—Vertigo—Epirubicin—hematologic cancer	0.000188	0.000218	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—hematologic cancer	0.000187	0.000216	CcSEcCtD
Cefadroxil—Dizziness—Triamcinolone—hematologic cancer	0.000183	0.000212	CcSEcCtD
Cefadroxil—Anaphylactic shock—Methotrexate—hematologic cancer	0.000183	0.000212	CcSEcCtD
Cefadroxil—Convulsion—Epirubicin—hematologic cancer	0.000182	0.00021	CcSEcCtD
Cefadroxil—Nausea—Etoposide—hematologic cancer	0.000181	0.00021	CcSEcCtD
Cefadroxil—Asthenia—Dexamethasone—hematologic cancer	0.00018	0.000209	CcSEcCtD
Cefadroxil—Asthenia—Betamethasone—hematologic cancer	0.00018	0.000209	CcSEcCtD
Cefadroxil—Thrombocytopenia—Methotrexate—hematologic cancer	0.000179	0.000207	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Prednisone—hematologic cancer	0.000179	0.000207	CcSEcCtD
Cefadroxil—Nausea—Prednisolone—hematologic cancer	0.000179	0.000207	CcSEcCtD
Cefadroxil—Arthralgia—Epirubicin—hematologic cancer	0.000179	0.000207	CcSEcCtD
Cefadroxil—Pruritus—Dexamethasone—hematologic cancer	0.000178	0.000206	CcSEcCtD
Cefadroxil—Pruritus—Betamethasone—hematologic cancer	0.000178	0.000206	CcSEcCtD
Cefadroxil—Vomiting—Triamcinolone—hematologic cancer	0.000176	0.000204	CcSEcCtD
Cefadroxil—Rash—Triamcinolone—hematologic cancer	0.000175	0.000202	CcSEcCtD
Cefadroxil—Dermatitis—Triamcinolone—hematologic cancer	0.000174	0.000202	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—hematologic cancer	0.000174	0.000202	CcSEcCtD
Cefadroxil—Urticaria—Prednisone—hematologic cancer	0.000174	0.000201	CcSEcCtD
Cefadroxil—Headache—Triamcinolone—hematologic cancer	0.000174	0.000201	CcSEcCtD
Cefadroxil—Abdominal pain—Prednisone—hematologic cancer	0.000173	0.0002	CcSEcCtD
Cefadroxil—Body temperature increased—Prednisone—hematologic cancer	0.000173	0.0002	CcSEcCtD
Cefadroxil—Diarrhoea—Dexamethasone—hematologic cancer	0.000172	0.000199	CcSEcCtD
Cefadroxil—Diarrhoea—Betamethasone—hematologic cancer	0.000172	0.000199	CcSEcCtD
Cefadroxil—Anaphylactic shock—Epirubicin—hematologic cancer	0.000171	0.000198	CcSEcCtD
Cefadroxil—Convulsion—Doxorubicin—hematologic cancer	0.000168	0.000195	CcSEcCtD
Cefadroxil—Thrombocytopenia—Epirubicin—hematologic cancer	0.000168	0.000194	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000167	0.000193	CcSEcCtD
Cefadroxil—Dizziness—Betamethasone—hematologic cancer	0.000166	0.000192	CcSEcCtD
Cefadroxil—Dizziness—Dexamethasone—hematologic cancer	0.000166	0.000192	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—hematologic cancer	0.000165	0.000191	CcSEcCtD
Cefadroxil—Nausea—Triamcinolone—hematologic cancer	0.000165	0.00019	CcSEcCtD
Cefadroxil—Somnolence—Methotrexate—hematologic cancer	0.000163	0.000188	CcSEcCtD
Cefadroxil—Hypersensitivity—Prednisone—hematologic cancer	0.000161	0.000187	CcSEcCtD
Cefadroxil—Dyspepsia—Methotrexate—hematologic cancer	0.000161	0.000186	CcSEcCtD
Cefadroxil—Vomiting—Betamethasone—hematologic cancer	0.00016	0.000185	CcSEcCtD
Cefadroxil—Vomiting—Dexamethasone—hematologic cancer	0.00016	0.000185	CcSEcCtD
Cefadroxil—Rash—Dexamethasone—hematologic cancer	0.000158	0.000183	CcSEcCtD
Cefadroxil—Rash—Betamethasone—hematologic cancer	0.000158	0.000183	CcSEcCtD
Cefadroxil—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000158	0.000183	CcSEcCtD
Cefadroxil—Dermatitis—Dexamethasone—hematologic cancer	0.000158	0.000183	CcSEcCtD
Cefadroxil—Dermatitis—Betamethasone—hematologic cancer	0.000158	0.000183	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000158	0.000183	CcSEcCtD
Cefadroxil—Headache—Betamethasone—hematologic cancer	0.000157	0.000182	CcSEcCtD
Cefadroxil—Headache—Dexamethasone—hematologic cancer	0.000157	0.000182	CcSEcCtD
Cefadroxil—Asthenia—Prednisone—hematologic cancer	0.000157	0.000182	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000156	0.00018	CcSEcCtD
Cefadroxil—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000155	0.000179	CcSEcCtD
Cefadroxil—Pruritus—Prednisone—hematologic cancer	0.000155	0.000179	CcSEcCtD
Cefadroxil—Somnolence—Epirubicin—hematologic cancer	0.000152	0.000176	CcSEcCtD
Cefadroxil—Dyspepsia—Epirubicin—hematologic cancer	0.000151	0.000174	CcSEcCtD
Cefadroxil—Diarrhoea—Prednisone—hematologic cancer	0.00015	0.000173	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Methotrexate—hematologic cancer	0.00015	0.000173	CcSEcCtD
Cefadroxil—Nausea—Dexamethasone—hematologic cancer	0.000149	0.000173	CcSEcCtD
Cefadroxil—Nausea—Betamethasone—hematologic cancer	0.000149	0.000173	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000148	0.000171	CcSEcCtD
Cefadroxil—Urticaria—Methotrexate—hematologic cancer	0.000145	0.000168	CcSEcCtD
Cefadroxil—Dizziness—Prednisone—hematologic cancer	0.000145	0.000167	CcSEcCtD
Cefadroxil—Abdominal pain—Methotrexate—hematologic cancer	0.000145	0.000167	CcSEcCtD
Cefadroxil—Body temperature increased—Methotrexate—hematologic cancer	0.000145	0.000167	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	0.000144	0.000167	CcSEcCtD
Cefadroxil—Somnolence—Doxorubicin—hematologic cancer	0.000141	0.000163	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Epirubicin—hematologic cancer	0.00014	0.000162	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—hematologic cancer	0.000139	0.000161	CcSEcCtD
Cefadroxil—Vomiting—Prednisone—hematologic cancer	0.000139	0.000161	CcSEcCtD
Cefadroxil—Rash—Prednisone—hematologic cancer	0.000138	0.00016	CcSEcCtD
Cefadroxil—Dermatitis—Prednisone—hematologic cancer	0.000138	0.00016	CcSEcCtD
Cefadroxil—Headache—Prednisone—hematologic cancer	0.000137	0.000159	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000137	0.000158	CcSEcCtD
Cefadroxil—Urticaria—Epirubicin—hematologic cancer	0.000136	0.000157	CcSEcCtD
Cefadroxil—Body temperature increased—Epirubicin—hematologic cancer	0.000135	0.000157	CcSEcCtD
Cefadroxil—Abdominal pain—Epirubicin—hematologic cancer	0.000135	0.000157	CcSEcCtD
Cefadroxil—Hypersensitivity—Methotrexate—hematologic cancer	0.000135	0.000156	CcSEcCtD
Cefadroxil—Asthenia—Methotrexate—hematologic cancer	0.000131	0.000152	CcSEcCtD
Cefadroxil—Nausea—Prednisone—hematologic cancer	0.00013	0.00015	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.00013	0.00015	CcSEcCtD
Cefadroxil—Pruritus—Methotrexate—hematologic cancer	0.000129	0.00015	CcSEcCtD
Cefadroxil—Hypersensitivity—Epirubicin—hematologic cancer	0.000126	0.000146	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—hematologic cancer	0.000126	0.000146	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—hematologic cancer	0.000125	0.000145	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—hematologic cancer	0.000125	0.000145	CcSEcCtD
Cefadroxil—Diarrhoea—Methotrexate—hematologic cancer	0.000125	0.000145	CcSEcCtD
Cefadroxil—Asthenia—Epirubicin—hematologic cancer	0.000123	0.000142	CcSEcCtD
Cefadroxil—Pruritus—Epirubicin—hematologic cancer	0.000121	0.00014	CcSEcCtD
Cefadroxil—Dizziness—Methotrexate—hematologic cancer	0.000121	0.00014	CcSEcCtD
Cefadroxil—Diarrhoea—Epirubicin—hematologic cancer	0.000117	0.000136	CcSEcCtD
Cefadroxil—Hypersensitivity—Doxorubicin—hematologic cancer	0.000117	0.000135	CcSEcCtD
Cefadroxil—Vomiting—Methotrexate—hematologic cancer	0.000116	0.000135	CcSEcCtD
Cefadroxil—Rash—Methotrexate—hematologic cancer	0.000115	0.000133	CcSEcCtD
Cefadroxil—Dermatitis—Methotrexate—hematologic cancer	0.000115	0.000133	CcSEcCtD
Cefadroxil—Headache—Methotrexate—hematologic cancer	0.000115	0.000133	CcSEcCtD
Cefadroxil—Asthenia—Doxorubicin—hematologic cancer	0.000114	0.000132	CcSEcCtD
Cefadroxil—Dizziness—Epirubicin—hematologic cancer	0.000113	0.000131	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—hematologic cancer	0.000112	0.00013	CcSEcCtD
Cefadroxil—Vomiting—Epirubicin—hematologic cancer	0.000109	0.000126	CcSEcCtD
Cefadroxil—Nausea—Methotrexate—hematologic cancer	0.000109	0.000126	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—hematologic cancer	0.000108	0.000125	CcSEcCtD
Cefadroxil—Rash—Epirubicin—hematologic cancer	0.000108	0.000125	CcSEcCtD
Cefadroxil—Dermatitis—Epirubicin—hematologic cancer	0.000108	0.000125	CcSEcCtD
Cefadroxil—Headache—Epirubicin—hematologic cancer	0.000107	0.000124	CcSEcCtD
Cefadroxil—Dizziness—Doxorubicin—hematologic cancer	0.000105	0.000121	CcSEcCtD
Cefadroxil—Nausea—Epirubicin—hematologic cancer	0.000102	0.000118	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—hematologic cancer	0.000101	0.000117	CcSEcCtD
Cefadroxil—Rash—Doxorubicin—hematologic cancer	9.99e-05	0.000116	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—hematologic cancer	9.98e-05	0.000115	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—hematologic cancer	9.92e-05	0.000115	CcSEcCtD
Cefadroxil—Nausea—Doxorubicin—hematologic cancer	9.41e-05	0.000109	CcSEcCtD
